{"organizations": [], "uuid": "a65e15394e7bcbe6b5a1233f3dc447918e84c85b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 1}, "facebook": {"likes": 3, "shares": 3, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XE879_3lpxc_TOP_20180126192049.jpg", "site_section": "https://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/sec-alleges-insider-trading-ahead-of-sanofis-purchase-of-bioverativ-1517012667", "country": "US", "domain_rank": 387, "title": "SEC Alleges Insider Trading Ahead of Sanofi’s Purchase of Bioverativ", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.006, "site_type": "news", "published": "2018-01-27T03:24:00.000+02:00", "replies_count": 0, "uuid": "a65e15394e7bcbe6b5a1233f3dc447918e84c85b"}, "author": "Dave Michaels", "url": "https://www.wsj.com/articles/sec-alleges-insider-trading-ahead-of-sanofis-purchase-of-bioverativ-1517012667", "ord_in_thread": 0, "title": "SEC Alleges Insider Trading Ahead of Sanofi’s Purchase of Bioverativ", "locations": [], "entities": {"persons": [], "locations": [{"name": "bioverativ washington", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "manhattan", "sentiment": "none"}, {"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "sanofi", "sentiment": "negative"}, {"name": "securities and exchange commission", "sentiment": "none"}, {"name": "credit suisse", "sentiment": "none"}, {"name": "sanofi sa", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WASHINGTON—U.S. securities regulators on Friday sued to freeze the profits of people who are alleged to have scored a windfall this week by trading on illegal tips about Sanofi SA’s $11.5 billion purchase of hemophilia drugmaker Bioverativ.\nThe Securities and Exchange Commission filed the suit in federal district court in Manhattan and said the traders’ identities is unknown. The lawsuit seeks an order that would force Credit Suisse, which processed the trades through an account in Zurich, to disclose the traders’ names.\n... ", "external_links": [], "published": "2018-01-27T03:24:00.000+02:00", "crawled": "2018-01-27T04:51:54.025+02:00", "highlightTitle": ""}